Correlation Between Salarius Pharmaceuticals and Magenta Therapeutics

Can any of the company-specific risk be diversified away by investing in both Salarius Pharmaceuticals and Magenta Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salarius Pharmaceuticals and Magenta Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Salarius Pharmaceuticals and Magenta Therapeutics, you can compare the effects of market volatilities on Salarius Pharmaceuticals and Magenta Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salarius Pharmaceuticals with a short position of Magenta Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salarius Pharmaceuticals and Magenta Therapeutics.

Diversification Opportunities for Salarius Pharmaceuticals and Magenta Therapeutics

0.0

Correlation Coefficient

Salarius Pharmaceuticals  Magenta Therapeutics

Pay attention - limited upside

The 3 months correlation between Salarius and Magenta is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Salarius Pharmaceuticals and Magenta Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Magenta Therapeutics and Salarius Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salarius Pharmaceuticals are associated (or correlated) with Magenta Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Magenta Therapeutics has no effect on the direction of Salarius Pharmaceuticals i.e., Salarius Pharmaceuticals and Magenta Therapeutics go up and down completely randomly.

Pair Corralation between Salarius Pharmaceuticals and Magenta Therapeutics

If you would invest  148.00  in Salarius Pharmaceuticals on December 1, 2024 and sell it today you would lose (40.00) from holding Salarius Pharmaceuticals or give up 27.03% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Salarius Pharmaceuticals  vs.  Magenta Therapeutics

Salarius Pharmaceuticals

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Salarius Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Salarius Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Magenta Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Magenta Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Magenta Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Salarius Pharmaceuticals and Magenta Therapeutics

The main advantage of trading using opposite Salarius Pharmaceuticals and Magenta Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salarius Pharmaceuticals position performs unexpectedly, Magenta Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Magenta Therapeutics will offset losses from the drop in Magenta Therapeutics' long position.

The idea behind Salarius Pharmaceuticals and Magenta Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.